Brief: Iteos Therapeutics Tigit Program Clinical Data Readouts Anticipated In 2024
Jan 8 (Reuters) - Iteos Therapeutics Inc ITOS.O :
* ITEOS THERAPEUTICS INC - TIGIT PROGRAM CLINICAL DATA
READOUTS
ANTICIPATED IN 2024
* ITEOS THERAPEUTICS INC - CASH BALANCE AND INVESTMENT
BALANCE OF
$644.9 MILLION AS OF SEPTEMBER 30, 2023 EXPECTED TO PROVIDE
RUNWAY THROUGH 2026
* ITEOS THERAPEUTICS INC - EOS-984 PRECLINICAL DATA
DEMONSTRATING
NOVEL MECHANISM OF ACTION IN ADENOSINE PATHWAY ANTICIPATED IN Q2
OF 2024
Source text for Eikon: ID:nGNX8q13Tq
Further company coverage: ITOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on iTeos Therapeutics
See all newsIteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive